Mga Batayang Estadistika
| LEI | 549300KNB8BMJ5TPCU58 |
| CIK | 1850502 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Enphys Acquisition Corp. Units Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-40879 Enphys Acquisition Corp. (Exact name of registrant as specified i |
|
| October 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2024 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporat |
|
| October 10, 2024 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange ("NYSE" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of Class A ordinary shares, Units, each consisting of one Class A ordinary share and one-half of a redeemable warrant, and Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11. |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2024 (September 10, 2024) Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jur |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of regi |
|
| August 13, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 001-40879 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Repor |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2024 (July 24, 2024) Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction |
|
| June 28, 2024 |
SC 13G/A 1 tm2417765d15sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2) Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, $0.0001 par value (Title of Cl |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2024 (June 5, 2024) Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction o |
|
| June 11, 2024 |
Exhibit 10.2 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| June 11, 2024 |
Exhibit 3.1 AMENDMENT TO THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF ENPHYS ACQUISITION CORP. JUNE 5, 2024 RESOLVED, as a special resolution, that: (i) Article 166(a) of the Amended and Restated Articles of Association of Enphys Acquisition Corp. be deleted in its entirety and replaced as follows: “166(a) In the event that the Company does not consummate a Business Combinati |
|
| June 11, 2024 |
Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of reg |
|
| May 16, 2024 |
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 811 Main Street, Suite 2500 | Houston, TX 77002 | T 713.821.7000 | F 713.821.7001 Holland & Knight LLP | www.hklaw.com Douglas C. Lionberger 713.244.8221 [email protected] May 16, 2024 VIA EDGAR Mr. Ruairi Regan Ms. Pam Long U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Re: Enphys Acqui |
|
| May 16, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| May 15, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 001-40879 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Repo |
|
| May 6, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D |
|
| April 16, 2024 |
Exhibit 4.4 DESCRIPTION OF SECURITIES We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Law and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 300,000,000 Class A ordinary shares and 30,000,000 Class B o |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specifie |
|
| April 1, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 001-40879 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition R |
|
| March 5, 2024 |
First Amendment to 2023 Promissory Note, dated as of March 1, 2024. (8) Exhibit 10.1 FIRST AMENDMENT TO PROMISSORY NOTE This FIRST AMENDMENT TO PROMISSORY NOTE (this “Amendment”) is made and entered into effective as of the 1st day of March, 2024 (the “Amendment Effective Date”), by and among Enphys Acquisition Sponsor LLC, a Delaware limited liability company (“Payee”) and Enphys Acquisition Corp., a Cayman Islands exempted company (“Maker”). WITNESSETH: WHEREAS, Mak |
|
| March 5, 2024 |
Exhibit 10.2 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| March 5, 2024 |
Exhibit 10.3 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| March 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2024 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation |
|
| February 14, 2024 |
SC 13G/A 1 firtree-nfys123123a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Enphys Acquisition Corp (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L125 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this State |
|
| February 13, 2024 |
EX-99.A 2 d676537dex99a.htm EX-99.A Exhibit A Lists of the relevant subsidiaries Subsidiary Principal business office Classification Mizuho Bank, Ltd 1–5–5, Otemachi, Chiyoda–ku, Tokyo 100–8176, Japan A non-U.S. institution equivalent to Bank Mizuho Americas LLC 1271 Avenue of the Americas, NY, NY 10020, USA A parent holding company Mizuho Securities USA LLC 1271 Avenue of the Americas, NY, NY 100 |
|
| February 13, 2024 |
EX-99.B 3 d676537dex99b.htm EX-99.B Exhibit B Power of Attorney Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations thereunder, the undersigned, in the undersigned capacity as an authorized representative of Mizuho Bank, Ltd., Mizuho Americas LLC and Mizuho Securities USA LLC (collectively, the “Companies”), hereby g |
|
| February 13, 2024 |
SC 13G 1 d676537dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Enphys Acquisition Corp. (Name of Issuer) Common Shares (Title of Class of Securities) G3167L125 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 13, 2024 |
SC 13G/A 1 nfysa221324.htm CAAS CAPITAL MANAGEMENT LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L109 (CUSIP Number) December 29, 2023 (Date of Event which Requires F |
|
| February 12, 2024 |
Joint Filing Agreement, dated as of February 12, 2024, by and among the Reporting Persons EX-99.1 2 ea193066ex99-1enphys.htm JOINT FILING AGREEMENT, DATED AS OF FEBRUARY 12, 2024, BY AND AMONG THE REPORTING PERSONS EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as a |
|
| February 12, 2024 |
SC 13G/A 1 ea193066-13ga1cantorenphys.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 Enphys Acquisition Corp (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G3167L109 (CUSIP Number) December 31, 2023 (Date of Ev |
|
| February 12, 2024 |
NFYS / Enphys Acquisition Corp. / ARISTEIA CAPITAL LLC Passive Investment SC 13G/A 1 formenphyssc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 1) Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporat |
|
| February 7, 2024 |
Second Extension Note, dated as of February 6, 2024 and issued to Enphys Management Company LLC. (7) Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| February 6, 2024 |
NFYS / Enphys Acquisition Corp. / TEACHER RETIREMENT SYSTEM OF TEXAS Passive Investment §240.13d-102 Schedule 13G §240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to §240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to §240.13d-2. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2) Enphys Acquisition Corp. (Name of Issuer) Class A ordinary sha |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2024 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporat |
|
| February 5, 2024 |
Amendment to the Amended and Restated Memorandum and Articles of Association. (4) Exhibit 3.1 AMENDMENT TO THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF ENPHYS ACQUISITION CORP. FEBRUARY 2, 2024 RESOLVED, as a special resolution, that: (i) Article 166(a) of the Amended and Restated Articles of Association of Enphys Acquisition Corp. be deleted in its entirety and replaced as follows: “166(a) In the event that the Company does not consummate a Business Combi |
|
| January 26, 2024 |
Power of Attorney, dated as of December 22, 2022 filed by the Reporting Persons on January 26, 2024. EXHIBIT 99.2 LIMITED POWER OF ATTORNEY Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or |
|
| January 26, 2024 |
Joint Filing Agreement, dated as of January 26, 2024, among the Reporting Persons. Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Shares of ENPHYS ACQUISITION CORP. dated as of December 31, 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the previsions of Rule13d-1(k) under |
|
| January 26, 2024 |
NFYS / Enphys Acquisition Corp. / Magnetar Financial LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 – Exit Filing)* ENPHYS ACQUISITION CORP. (Name of Issuer) Common Stock – Class A (Title of Class of Securities) G3167L109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| January 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment and Supplement No. 2) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| January 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment and Supplement No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| January 12, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ |
|
| December 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of |
|
| November 15, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2023 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporat |
|
| October 30, 2023 |
Promissory Note, dated as of October 30, 2023 and issued to Enphys Acquisition Sponsor LLC. Exhibit 10.1 THIS PROMISSORY NOTE (THIS “NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| October 23, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 17, 2023 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation) (Co |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2023 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporat |
|
| October 10, 2023 |
Extension Note, dated as of October 10, 2023 and issued to Enphys Acquisition Sponsor LLC. (5) Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| October 6, 2023 |
Amendment to the Amended and Restated Memorandum and Articles of Association. (3) Exhibit 3.1 AMENDMENT TO THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF ENPHYS ACQUISITION CORP. OCTOBER 6, 2023 RESOLVED, as a special resolution, that: (i) Article 166(a) of the Amended and Restated Articles of Association of Enphys Acquisition Corp. be deleted in its entirety and replaced as follows: “166(a) In the event that the Company does not consummate a Business Combin |
|
| October 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2023 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporati |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment and Supplement No. 2) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy S |
|
| September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment and Supplement No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1 |
|
| September 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy S |
|
| September 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy S |
|
| September 11, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| September 8, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| September 8, 2023 |
Richard Brand Via E-Mail T: +1 212 504 5757 [email protected] United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jeffrey Gabor September 8, 2023 Re: Enphys Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed August 24, 2023 CIK No. 1850502 Dear Mr. Gabor: On behalf of our client, Enphys Acquisition Co |
|
| August 24, 2023 |
false000185050200018505022023-08-182023-08-180001850502nfys:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassAOrdinarySharesAtAnExercisePriceOf1150Member2023-08-182023-08-180001850502us-gaap:CommonClassAMember2023-08-182023-08-180001850502nfys:UnitsEachConsistingOfOneClassAOrdinarySharesAndOneHalfOfOneRedeemableWarrantMember2023-08-182023-08-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 24, 2023 |
Enphys Acquisition Corp. Announces Non-Binding Letter of Intent to Acquire Advanced Biofuels Company Exhibit 99.1 Enphys Acquisition Corp. Announces Non-Binding Letter of Intent to Acquire Advanced Biofuels Company New York, NY (August 24, 2023) - Enphys Acquisition Corp. (NYSE: NFYS) (the “Company”) today announced that following four months of negotiations, due diligence and site visits, it signed a non-binding letter of intent for a business combination with a leading and well-established adva |
|
| August 24, 2023 |
Enphys Acquisition Corp. Announces Non-Binding Letter of Intent to Acquire Advanced Biofuels Company Exhibit 99.1 Enphys Acquisition Corp. Announces Non-Binding Letter of Intent to Acquire Advanced Biofuels Company New York, NY (August 24, 2023) - Enphys Acquisition Corp. (NYSE: NFYS) (the “Company”) today announced that following four months of negotiations, due diligence and site visits, it signed a non-binding letter of intent for a business combination with a leading and well-established adva |
|
| August 24, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2023 Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation) (Com |
|
| August 23, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D |
|
| August 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of regi |
|
| August 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Repor |
|
| June 20, 2023 |
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] Cadwalader, Wickersham & Taft LLP 200 Liberty Street, New York, NY 10281 Tel +1 212 504 6000 Fax +1 212 504 6666 www. |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of reg |
|
| May 15, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Repo |
|
| April 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specifie |
|
| April 13, 2023 |
Exhibit 4.4 DESCRIPTION OF SECURITIES We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Law and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 300,000,000 Class A ordinary shares and 30,000,000 Class B o |
|
| March 31, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition R |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, $0.0001 par value (Title of Class of Securities) G3167L109 (CUSIP Number |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 13, 2023 |
KYG3167L1095 / Enphys Acquisition Corp. / ARISTEIA CAPITAL LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2023 |
SC 13G/A 1 nfys.ua121023.htm CAAS CAPITAL MANAGEMENT LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L125 (CUSIP Number) December 30, 2022 (Date of Event which Requires |
|
| February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L109 (CUSIP Number) December 30, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| January 27, 2023 |
KYG3167L1095 / Enphys Acquisition Corp. / Magnetar Financial LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Enphys Acquisition Corp. (Name of Issuer) Common Stock – Class A (Title of Class of Securities) G3167L109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 27, 2023 |
EXHIBIT 99.2 LIMITED POWER OF ATTORNEY Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or |
|
| January 27, 2023 |
EX-99.1 2 tm234504d18ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Shares of Enphys Acquisition Corp. dated as of December 31, 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accorda |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of re |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of |
|
| November 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2022 Enphys Acquisition Corp. (Exact name of registrant as specified in charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation) Commis |
|
| November 15, 2022 |
NT 10-Q 1 brhc10044270nt10q.htm NT 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CAR For Period Ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tran |
|
| October 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 Enphys Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G3167L109 (CUSIP Number) October 11, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| October 17, 2022 |
Joint Filing Agreement, dated as of October 17, 2022, by and among the Reporting Persons EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the und |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of regi |
|
| August 5, 2022 |
§240.13d-102 Schedule 13G §240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to §240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to §240.13d-2. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1) Enphys Acquisition Corp. (Name of Issuer) Class A ordinary sha |
|
| May 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of reg |
|
| May 16, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CAR For Period Ended: March 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Repo |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specifie |
|
| April 22, 2022 |
ENPHYS ACQUISITION CORP. ANNOUNCES RECEIPT OF NOTICE OF LATE FILING FROM NYSE Exhibit 99.1 ENPHYS ACQUISITION CORP. ANNOUNCES RECEIPT OF NOTICE OF LATE FILING FROM NYSE New York, NY (April 22, 2022) ? Enphys Acquisition Corp. (the ?Company?) announced that it that received a notice from the New York Stock Exchange (the ?NYSE?) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 18, 2022 Enphys Acquisition Corp. (Exact name of registrant as specified in charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation) Commissio |
|
| April 22, 2022 |
Exhibit 4.4 DESCRIPTION OF SECURITIES We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Law and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 300,000,000 Class A ordinary shares and 30,000,000 Class B o |
|
| April 1, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 005-91594 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CAR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition R |
|
| March 21, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. )* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G3167L125** (CUSIP Number) December 3 |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
SC 13G/A 1 tm225641d46sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, $0.0001 par value (Title of Cl |
|
| February 10, 2022 |
SC 13G 1 d314172dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 Enphys Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G3167L125 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statem |
|
| February 10, 2022 |
Exhibit 1 AGREEMENT OF JOINT FILING This joint filing agreement (this ?Agreement?) is made and entered into as of this 10th day of February 2022, by and among Enphys Acquisition Sponsor LLC and Jorge de Pablo. |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, $0.0001 par value per share (Title of Class of Securities) G3167L109 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Enphys Acquisition Corp. (Name of Issuer) Common Stock – Class A (Title of Class of Securities) G3167L125 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| December 8, 2021 |
?240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to ?240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to ?240.13d-2. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.) Enphys Acquisition Corp. (Name of Issuer) Units, each consisting of one Class A ordinary |
|
| November 24, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: ENPHYS ACQUISITION CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT NOVEMBER 26, 2021 New York, NY (November 24, 2021) ? Enphys Acquisition Corp. (the ?Company?) announced that commencing on or about November 26, 2021, the holders of the units sold in the Company?s initial public offering of 34,500,000 unit |
|
| November 24, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 24, 2021 Enphys Acquisition Corp. (Exact name of registrant as specified in charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation) Commis |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of |
|
| October 21, 2021 |
Enphys Acquisition Corp. INDEX TO FINANCIAL STATEMENT Exhibit 99.1 Enphys Acquisition Corp. INDEX TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of October 8, 2021 F-3 Notes to Balance Sheet F-4 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shareholders and Board of Directors Enphys Acquisition Corp. New York, NY Opinion on the Financial Statement We have audited the accompanying |
|
| October 21, 2021 |
Financial Statements and Exhibits, Other Events 8-K 1 brhc100298488k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 8, 2021 Enphys Acquisition Corp. (Exact Name of Registrant as Specified in Charter) Cayman Islands 001-40879 87-2010879 (State or Other Jurisdicti |
|
| October 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Enphys Acquisition Corp. |
|
| October 12, 2021 |
Form of Upsizing Letter Agreement by and between the Company and each of the anchor investors. (2) Exhibit 10.8 Enphys Acquisition Corp. 216 East 45th Street, 13th Floor New York, New York 10017 October [?], 2021 [Subscriber] [Notice Address] [City, State Zip] Re: Subscription Agreement Ladies and Gentlemen: Reference is made to that certain Subscription Agreement of even date herewith by and between the Company and Subscriber (the ?Subscription Agreement?). Capitalized terms used but not other |
|
| October 12, 2021 |
EX-1.1 2 nt10021332x22ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 Execution Version $300,000,000 30,000,000 Units Enphys Acquisition Corp. UNDERWRITING AGREEMENT October 5, 2021 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 As Representative of the several Underwriters Ladies and Gentlemen: Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), propo |
|
| October 12, 2021 |
Exhibit 4.1 WARRANT AGREEMENT ENPHYS ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY October 5, 2021 THIS WARRANT AGREEMENT (this ?Agreement?), October 5, 2021, is by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, t |
|
| October 12, 2021 |
Exhibit 99.2 Enphys Acquisition Corp. Announces Closing of Initial Public Offering, including the full Amount of the Underwriters? Over-Allotment Option, for Total Gross Proceeds of $345 Million October 8, 2021 - NEW YORK - Enphys Acquisition Corp. (NYSE: NFYS.U; the ?Company?) announced today that it closed its upsized initial public offering of 30,000,000 units together with the issuance of an a |
|
| October 12, 2021 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of October 5, 2021, is made and entered into by and among Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Enphys Acquisition Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), and any other parties listed on the signature page hereto (together |
|
| October 12, 2021 |
Exhibit 10.4 SPONSOR WARRANTS PURCHASE AGREEMENT THIS SPONSOR WARRANTS PURCHASE AGREEMENT, dated as of October 5, 2021 (as it may from time to time be amended, this ?Agreement?), is entered into by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Enphys Acquisition Sponsor LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS: The Company |
|
| October 12, 2021 |
8-K 1 nt10021332x228k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 5, 2021 Enphys Acquisition Corp. (Exact Name of Registrant as Specified in Charter) Cayman Islands 001-40879 87-2010879 (State or Other Jurisdict |
|
| October 12, 2021 |
Exhibit 10.1 October 5, 2021 Enphys Acquisition Corp. c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into or proposed to be entered into by and between Enphys Acquis |
|
| October 12, 2021 |
Enphys Acquisition Corp. Announces Pricing of Upsized $300 Million Initial Public Offering Exhibit 99.1 Enphys Acquisition Corp. Announces Pricing of Upsized $300 Million Initial Public Offering October 5, 2021 - NEW YORK - Enphys Acquisition Corp. (the ?Company?) announced today the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the ?NYSE?) and trade under the ticker symbol ?NFYS.U? begi |
|
| October 12, 2021 |
Exhibit 10.5 Enphys Acquisition Corp. c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 October 5, 2021 Enphys Acquisition Sponsor LLC c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 Re: Administrative Services Agreement Ladies and Gentlemen: This Administrative Services Agreement (this ?Agreement?) by and between Enphys Acquisiti |
|
| October 12, 2021 |
Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of October 5, 2021, by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No |
|
| October 12, 2021 |
Amended and Restated Memorandum and Articles of Association. (2) Exhibit 3.1 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES amended and restated Memorandum OF association of ENPHYS ACQUISITION CORP. (Adopted by special resolution dated 5 OCTOBER 2021) 190 Elgin Avenue. George Town Grand Cayman KY1-9001, Cayman Islands T +1 345 949 0100 F +1 345 949 7886 www.walkersglobal.com Ref: CBD/JH/E-169584 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES |
|
| October 7, 2021 |
$300,000,000 ENPHYS ACQUISITION CORP. 30,000,000 Units TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(4) Registration Statement Nos. 333-257932 and 333-260082 Prospectus $300,000,000 ENPHYS ACQUISITION CORP. 30,000,000 Units Enphys Acquisition Corp. is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorg |
|
| October 6, 2021 |
Radcliffe Capital Management, L.P. - SC 13G SC 13G 1 tm2129388d1sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. ) Enphys Acquisition Corp. (Name of Issuer) Class A ordinary shares, $0.0001 par value (Title of Class of |
|
| October 5, 2021 |
8-A12B 1 nt10021332x168a12b.htm FORM 8/A-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 87-2010879 (State of Incorporation or Organization) (I.R. |
|
| October 5, 2021 |
As filed with the Securities and Exchange Commission on October 5, 2021. S-1MEF 1 nt10021332x18s1mef.htm FORM S-1MEF As filed with the Securities and Exchange Commission on October 5, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 6770 87-2010879 (State or |
|
| October 4, 2021 |
ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 October 4, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E. Washington, DC 20549 Attention: Nicholas Lamparski Dietrich King Re: Enphys Acquisition Corp. Registration Statement on Form S-1, as amended (File No. 333-257932) Request for Acceleratio |
|
| October 4, 2021 |
ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 CORRESP 1 filename1.htm ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 October 4, 2021 VIA EDGAR AND ELECTRONIC MAIL Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E. Washington, DC 20549 Attention: Nicholas Lamparski Dietrich King Re: Enphys Acquisition Corp. Registration Statement on Form S-1, as amended ( |
|
| October 4, 2021 |
* * * [Signature Page Follows] CORRESP 1 filename1.htm October 4, 2021 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Nicholas Lamparski Mara Ransom Re: Enphys Acquisition Corp. Registration Statement on Form S-1, as amended Registration File No. 333-257932 Dear Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on Septembe |
|
| October 4, 2021 |
[Signature Page to Underwriter’s Acceleration Request] Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 October 4, 2021 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| September 30, 2021 |
[Signature Page to Underwriter’s Acceleration Request] CORRESP 1 filename1.htm Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 September 30, 2021 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Nicholas Lamparski Mara Ransom Re: Enphys Acquisition Corp. Registration Statement on Form S-1, as amended Registration File No. 333-257932 Ladies and Gentlemen |
|
| September 30, 2021 |
ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 CORRESP 1 filename1.htm ENPHYS ACQUISITION CORP. 216 EAST 45TH STREET 13TH FLOOR NEW YORK NY 10017 September 30, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E. Washington, DC 20549 Attention: Nicholas Lamparski Dietrich King Re: Enphys Acquisition Corp. Registration Statement on Form S-1, as amended (File No. 333-2579 |
|
| September 1, 2021 |
As filed with the Securities and Exchange Commission on August 31, 2021 S-1/A 1 nt10021332x10s1a.htm S/1A TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 31, 2021 Registration No. 333-257932 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islan |
|
| August 31, 2021 |
CORRESP 1 filename1.htm August 31, 2021 FILED VIA EDGAR Division of Corporation Finance Office of Trade and Services Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Enphys Acquisition Corp. Amendment No. 3 to Registration Statement on Form S-1 Filed on August 27, 2021 File No. 333-257932 Ladies and Gentlemen: On behalf of our client, Enphys Acquisition Corp., a Cay |
|
| August 27, 2021 |
As filed with the Securities and Exchange Commission on August 26, 2021 S-1/A 1 nt10021332x8s1a.htm S-1/A TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 26, 2021 Registration No. 333-257932 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islan |
|
| August 27, 2021 |
EXHIBIT 4.4 WARRANT AGREEMENT ENPHYS ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [?], 2021 THIS WARRANT AGREEMENT (this ?Agreement?), dated [?], 2021, is by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent? |
|
| August 26, 2021 |
CORRESP 1 filename1.htm August 26, 2021 FILED VIA EDGAR Division of Corporation Finance Office of Trade and Services Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Enphys Acquisition Corp. Amendment No. 2 to Registration Statement on Form S-1 Filed on August 20, 2021 File No. 333-257932 Ladies and Gentlemen: On behalf of our client, Enphys Acquisition Corp., a Cay |
|
| August 20, 2021 |
As filed with the Securities and Exchange Commission on August 19, 2021 S-1/A 1 nt10021332x5s1a.htm S-1/A TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 19, 2021 Registration No. 333-257932 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islan |
|
| August 19, 2021 |
August 19, 2021 FILED VIA EDGAR Division of Corporation Finance Office of Trade and Services Securities and Exchange Commission 100 F Street, N. |
|
| August 13, 2021 |
CONSENT OF FEDERICO CARRILO-ZURCHER EX-99.3 19 nt10021332x7ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 CONSENT OF FEDERICO CARRILO-ZURCHER In connection with the filing by Enphys Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of th |
|
| August 13, 2021 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Enphys Acquisition Sponsor LLC, a Delaware limited liability company (the ?Sponsor?), and any other parties listed on the signature page hereto (together with t |
|
| August 13, 2021 |
Form of Code of Ethics and Business Conduct. (1) EX-14 16 nt10021332x7ex14.htm EXHIBIT 14 Exhibit 14 [FORM OF] CODE OF ETHICS AND BUSINESS CONDUCT OF ENPHYS ACQUISITION CORP. 1. Introduction The Board of Directors (the “Board”) of Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), has adopted this code of ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s dire |
|
| August 13, 2021 |
As filed with the Securities and Exchange Commission on August 13 , 2021 S-1/A 1 nt10021332x7s1a.htm S-1/A As filed with the Securities and Exchange Commission on August 13 , 2021 Registration No. 333-257932 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 6770 87-201087 |
|
| August 13, 2021 |
$250,000,000 25,000,000 Units Enphys Acquisition Corp. UNDERWRITING AGREEMENT EX-1.1 2 nt10021332x7ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 $250,000,000 25,000,000 Units Enphys Acquisition Corp. UNDERWRITING AGREEMENT [•] 2021 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 As Representative of the several Underwriters Ladies and Gentlemen: Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), proposes to sell to you and, as |
|
| August 13, 2021 |
CONSENT OF JOSE ANTONIO AGUILAR BUENO EX-99.2 18 nt10021332x7ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 CONSENT OF JOSE ANTONIO AGUILAR BUENO In connection with the filing by Enphys Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of |
|
| August 13, 2021 |
Exhibit 99.8 CHARTER OF THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS OF ENPHYS ACQUISITION CORP. ADOPTED ON , 2021 I. PURPOSE OF THE COMMITTEE The purposes of the Nominating and Corporate Governance Committee (the ?Committee?) of the Board of Directors (the ?Board?) of Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), shall be to identify a |
|
| August 13, 2021 |
Form of Subscription Agreement by and between the Company and each of the anchor investors. (2) EX-10.9 15 nt10021332x7ex10-9.htm EXHIBIT 10.9 Exhibit 10.9 SUBSCRIPTION AGREEMENT THIS AGREEMENT (this “Agreement”), is dated as of [], 2021, by and between Enphys Acquisition Corp., a Cayman Islands exempted corporation (the “Company”), and [], a [] (“Subscriber”). WHEREAS, the Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purcha |
|
| August 13, 2021 |
Exhibit 99.5 CONSENT OF EVA REDHE In connection with the filing by Enphys Acquisition Corp. (the ?Company?) of its Registration Statement (the ?Registration Statement?) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of |
|
| August 13, 2021 |
Exhibit 3.2 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF ENPHYS ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION DATED [?] 2021) THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF ENPHYS ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION DATED [?] 2021) 1. The name of the company is |
|
| August 13, 2021 |
Exhibit 10.2 [], 2021 Enphys Acquisition Corp. 216 East 45th Street 13th Floor New York, New York 10017 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into or proposed to be entered into by and between Enphys Acquisition Corp., a Cayman Islands exe |
|
| August 13, 2021 |
CONSENT OF CARLOS N. GUIMARAES Exhibit 99.1 CONSENT OF CARLOS N. GUIMARAES In connection with the filing by Enphys Acquisition Corp. (the ?Company?) of its Registration Statement (the ?Registration Statement?) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the |
|
| August 13, 2021 |
Exhibit 10.8 Enphys Acquisition Corp. c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 [?], 2021 Enphys Acquisition Sponsor LLC c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 Re: Administrative Services Agreement Ladies and Gentlemen: This Administrative Services Agreement (this ?Agreement?) by and between Enphys Acquisition Cor |
|
| August 13, 2021 |
Form of Specimen Unit Certificate. (1) EX-4.1 4 nt10021332x7ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 SEE REVERSE FOR CERTAIN DEFINITIONS NUMBER UNITS U – CUSIP G3167L 125 ENPHYS ACQUISITION CORP. UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-HALF OF ONE REDEEMABLE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one (1) Cl |
|
| August 13, 2021 |
INVESTMENT MANAGEMENT TRUST AGREEMENT EX-10.3 10 nt10021332x7ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021, by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s re |
|
| August 13, 2021 |
Exhibit 10.7 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of [?], 2021. Between: (1) ENPHYS ACQUISITION CORP., an exempted company incorporated under the laws of the Cayman Islands with registered office at , Grand Cayman, KY1-1104, Cayman Islands (the ?Company?); and (2) [?] (?Indemnitee?). Whereas: (A) Highly competent persons have become more reluctant to serve pub |
|
| August 13, 2021 |
Form of Specimen Ordinary Share Certificate. (1) Exhibit 4.2 SEE REVERSE FOR CERTAIN DEFINITIONS NUMBER SHARES C ? CUSIP G3167L 109 ENPHYS ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF U.S.$0.0001 EACH OF ENPHYS ACQUISITION CORP. (THE ?COMPANY?) transferable on the register of members of the |
|
| August 13, 2021 |
Form of Specimen Warrant Certificate. (1) EX-4.4 6 nt10021332x7ex4-4.htm EXHIBIT 4.4 Exhibit 4.4 WARRANT AGREEMENT ENPHYS ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [•], 2021 THIS WARRANT AGREEMENT (this “Agreement”), dated [•], 2021, is by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant a |
|
| August 13, 2021 |
SPONSOR WARRANTS PURCHASE AGREEMENT Exhibit 10.6 SPONSOR WARRANTS PURCHASE AGREEMENT THIS SPONSOR WARRANTS PURCHASE AGREEMENT, dated as of [?], 2021 (as it may from time to time be amended, this ?Agreement?), is entered into by and between Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Enphys Acquisition Sponsor LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS: The Company intend |
|
| August 13, 2021 |
EX-99.4 20 nt10021332x7ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 CONSENT OF HELIO L. MAGALHAES In connection with the filing by Enphys Acquisition Corp. (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Secu |
|
| August 13, 2021 |
EX-99.6 22 nt10021332x7ex99-6.htm EXHIBIT 99.6 Exhibit 99.6 CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ENPHYS ACQUISITION CORP. ADOPTED ON , 2021 I. PURPOSE OF THE COMMITTEE The purpose of the Audit Committee (the “Committee”) of the Board of Directors (the “Board”) of Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), is to provide assistance to the Boar |
|
| August 13, 2021 |
Exhibit 99.7 CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF ENPHYS ACQUISITION CORP. ADOPTED ON , 2021 I. PURPOSE OF THE COMMITTEE The purposes of the Compensation Committee (the ?Committee?) of the Board of Directors (the ?Board?) of Enphys Acquisition Corp., a Cayman Islands exempted company (the ?Company?), shall be to oversee the Company?s compensation and employee benefit |
|
| July 15, 2021 |
CORRESP 1 filename1.htm July 15, 2021 FILED VIA EDGAR Division of Corporation Finance Office of Trade and Services Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Enphys Acquisition Corp. Draft Registration Statement on Form S-1 Submitted March 11, 2021 CIK No. 0001850502 Ladies and Gentlemen: On behalf of our client, Enphys Acquisition Corp. (the “Company”), we ar |
|
| July 15, 2021 |
EX-10.5 4 nt10021332x3ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 ENPHYS ACQUISITION CORP. c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 March 4, 2021 Enphys Acquisition Sponsor LLC c/o i(x) Investments, LLC 216 East 45th Street 13th Floor New York, New York 10017 RE: Securities Subscription Agreement Ladies and Gentlemen: Enphys Acquisition Corp., a Cayman Islands ex |
|
| July 15, 2021 |
IN THE MATTER OF THE COMPANIES ACT (AS AMENDED) IN THE MATTER ENPHYS ACQUISITION CORP. EX-3.1 2 nt10021332x3ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 IN THE MATTER OF THE COMPANIES ACT (AS AMENDED) AND IN THE MATTER OF ENPHYS ACQUISITION CORP. DECLARATION I, Andrew Barker, of George Town, Grand Cayman, Cayman Islands, HEREBY DECLARE as follows: 1. WNL Limited is a Subscriber of Enphys Acquisition Corp., a company applying for registration under the Companies Act (as amended). 2. The operati |
|
| July 15, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on July 15, 2021 Registration No. |
|
| July 15, 2021 |
Promissory Note, dated as of March 4, 2021, issued to Enphys Acquisition Sponsor LLC. (1) Exhibit 10.1 THIS PROMISSORY NOTE (THIS ?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COM |
|
| March 11, 2021 |
INFORMATION HEREIN REMAINS STRICTLY CONFIDENTIAL. DRS 1 filename1.htm TABLE OF CONTENTS AS SUBMITTED CONFIDENTIALLY WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 10, 2021. THIS DRAFT REGISTRATION STATEMENT HAS NOT BEEN PUBLICLY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION AND ALL INFORMATION HEREIN REMAINS STRICTLY CONFIDENTIAL. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 R |
|
| March 10, 2021 |
DRSLTR 1 filename1.htm JASON S. MCCAFFREY direct dial: 617.856.8362 fax: 617.289.0856 [email protected] March 10, 2021 CONFIDENTIAL SUBMISSION VIA EDGAR Draft Registration Statement U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, D.C. 20549 Re: Enphys Acquisition Corp. Draft Registration Statement on Form S-1 Ladies and Gentlemen: On |
